Back to search

United Kingdom· GB-APID-41843611000001109

Latex 200micrograms/ml solution for skin prick test

A medicinal product containing latex allergen extract, registered in United Kingdom by Inmunotek.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedLatex 200micrograms/ml solution for s…ATC—REGISTER NO.GB-APID-4184361100000…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Latex allergen extract
Manufacturer
Inmunotek
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca7bdf71-d7c4-42ef-84a7-82e68631c83c
GET /v1/drugs/ca7bdf71-d7c4-42ef-84a7-82e68631c83c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "41843611000001109",
  "desc": "Latex 200micrograms/ml solution for skin prick test (Inmunotek)",
  "form": "Solution for skin-prick test",
  "vpid": "41843811000001108",
  "source": "dmd",
  "vtm_id": null,
  "strength": null,
  "substance": null,
  "ingredient": "Latex allergen extract",
  "supplier_code": "41823811000001106"
}

See everything about latex allergen extract.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.